— Know what they know.
Not Investment Advice
Also trades as: MXCT.L (LSE) · $vol 0M

MXCT NASDAQ

MaxCyte, Inc.
1W: -2.8% 1M: +19.1% 3M: +43.4% YTD: -31.6% 1Y: -51.4% 3Y: -71.3%
$1.04
-0.02 (-1.89%)
 
Weekly Expected Move ±14.3%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Buy · Power 64 · $111.4M mcap · 99M float · 0.996% daily turnover · Short 14% of daily vol

Cash Flow Trends

Operating Cash Flow
-$34M -24.6% ▼
Capital Expenditures
$2M -7.1% ▼
5Y CAGR: -3.1%
Free Cash Flow
-$36M -23.6% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$8M +58.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$19M-$24M-$38M-$41M-$45M
Depreciation & Amort.$1M$3M$5M$4M$5M
Stock-Based Comp.$8M$0$14M$0$9M
Change in Working Capital-$2M-$3M$4M-$751K-$6M
Other Non-Cash Items$665K$9M-$6M$10M$2M
Operating Cash Flow-$11M-$15M-$22M-$28M-$34M
— Investing Activities —
Capital Expenditures-$4M-$18M-$4M-$2M-$2M
Acquisitions (Net)$0$0$0$0-$2M
Investment Purchases-$269M-$291M-$255M-$151M-$126M
Investment Sales$78M$285M$314M$159M$156M
Other Investing$5K$0$9K$0$0
Investing Cash Flow-$195M-$25M$55M$7M$26M
— Financing Activities —
Net Debt Issuance-$5M$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$4M$0$2M$0$0
Financing Cash Flow$235M$3M$2M$2M$656K
Net Change in Cash$29M-$37M$35M-$19M-$8M
Cash End of Period$48M$11M$47M$28M$20M
Free Cash Flow-$15M-$33M-$25M-$29M-$36M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms